Cargando…
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know
The development of vaccines to fight COVID-19 has been a remarkable medical achievement. However, this global immunization effort has been complicated by a rare vaccine-related outcome characterized by thrombocytopenia and thrombosis in association with platelet-activating anti–platelet factor 4 ant...
Autores principales: | Arepally, Gowthami M., Ortel, Thomas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172307/ https://www.ncbi.nlm.nih.gov/pubmed/34323940 http://dx.doi.org/10.1182/blood.2021012152 |
Ejemplares similares
-
Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023) -
Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?
por: Roytenberg, Renat, et al.
Publicado: (2023) -
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
por: Uzun, Günalp, et al.
Publicado: (2021) -
Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Blood. 2021;138(4):293-298.
Publicado: (2023) -
Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody
por: Wang, Jing Jing, et al.
Publicado: (2022)